Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to -$142000.0.

  • CV Sciences' Change in Receivables rose 3515.98% to -$142000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$27000.0, marking a year-over-year increase of 8992.54%. This contributed to the annual value of $84000.0 for FY2024, which is 12386.36% up from last year.
  • As of Q3 2025, CV Sciences' Change in Receivables stood at -$142000.0, which was up 3515.98% from $112000.0 recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Change in Receivables registered a high of $610000.0 during Q3 2021, and its lowest value of -$1.1 million during Q1 2022.
  • In the last 5 years, CV Sciences' Change in Receivables had a median value of $45000.0 in 2023 and averaged -$24947.4.
  • As far as peak fluctuations go, CV Sciences' Change in Receivables plummeted by 72406.02% in 2022, and later skyrocketed by 38260.87% in 2024.
  • Over the past 5 years, CV Sciences' Change in Receivables (Quarter) stood at $294000.0 in 2021, then tumbled by 63.61% to $107000.0 in 2022, then tumbled by 332.71% to -$249000.0 in 2023, then skyrocketed by 141.37% to $103000.0 in 2024, then tumbled by 237.86% to -$142000.0 in 2025.
  • Its last three reported values are -$142000.0 in Q3 2025, $112000.0 for Q2 2025, and -$100000.0 during Q1 2025.